The Human Papillomavirus E7 Oncoprotein Functionally Interacts with the S4 Subunit of the 26 S Proteasome*

Human papillomaviruses (HPV) have been etiologically linked to human cervical cancer. More than 90% of cervical cancer tissues express two HPV-encoded oncoproteins E6 and E7. Both E6 and E7 proteins possess transformation activity. and together they cooperate to transform primary human keratinocytes, fibroblasts. and epithelial cells. The transforming activity of E7 is associated with its ability to bind the retinoblastoma tumor suppressor protein (Rb). However, the carboxyl-terminal mutants of E7 are also defective for transformation, suggesting that other cellular targets for E7 might exist. We screened a human placenta cDNA library by yeast two-hybrid assay using HPV 16 E7 as a bait and identified the subunit 4 (S4) ATPase of the 26 S proteasome as a novel E7-binding protein. E7 binds to S4 through the carboxyl-terminal zinc binding motif, and the binding is independent of E7 sequences involved in binding to Rb. The interaction between S4 and E7 can be easily detected by in vitro protein binding assays. Moreover, we found that E7 increases the ATPase activity of S4. A recent study has shown that, in epithelial cells, E7 degrades Rb through the 26 S proteasome pathway. We hypothesize that E7 might target Rb for degradation by 26 S proteasome through its interaction with the subunit 4 of the proteasome.

[1]  D. Wazer,et al.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.

[2]  V C Emery,et al.  Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7. , 1996, The Biochemical journal.

[3]  W. Wang,et al.  Mammalian Sug1 and c-Fos in the nuclear 26S proteasome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K Tanaka,et al.  Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.

[5]  R. Brent,et al.  Dimerization of the human papillomavirus E7 oncoprotein in vivo. , 1995, Virology.

[6]  T. Maniatis,et al.  Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[8]  D. Wazer,et al.  Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Nelson,et al.  Cloning and Expression of a Yeast Gene Encoding a Protein with ATPase Activity and High Identity to the Subunit 4 of the Human 26 S Protease (*) , 1995, The Journal of Biological Chemistry.

[10]  K. Vousden.  Regulation of the cell cycle by viral oncoproteins. , 1995, Seminars in cancer biology.

[11]  H. Hausen,et al.  Human papillomaviruses. , 1994, Annual review of microbiology.

[12]  M. Newton,et al.  Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. , 1994, Genes & development.

[13]  Tom Maniatis,et al.  The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.

[14]  L. Staszewski,et al.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain , 1994, Cell.

[15]  H. Feilotter,et al.  Construction of an improved host strain for two hybrid screening. , 1994, Nucleic acids research.

[16]  Michael R. Green,et al.  Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains , 1994, Nature.

[17]  T. Tlsty,et al.  Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. , 1994, Genes & development.

[18]  E. Androphy,et al.  Cellular transformation by papilomavirus oncorproteins , 1993 .

[19]  C. Rosen,et al.  Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit , 1993, Nature.

[20]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[21]  P. Raychaudhuri,et al.  Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex , 1993, Molecular and cellular biology.

[22]  J. H. Schwartz,et al.  Regulatory subunits of cAMP-dependent protein kinases are degraded after conjugation to ubiquitin: a molecular mechanism underlying long-term synaptic plasticity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Andrew W. Murray,et al.  Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor , 1993, Cell.

[24]  S. Fields,et al.  Elimination of false positives that arise in using the two-hybrid system. , 1993, BioTechniques.

[25]  S. Grossman,et al.  Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding , 1993, Journal of virology.

[26]  M. Rechsteiner,et al.  The multicatalytic and 26 S proteases. , 1993, The Journal of biological chemistry.

[27]  D. Hartley.  Cellular interactions in development : a practical approach , 1993 .

[28]  K. Ferrell,et al.  Subunit 4 of the 26 S protease is a member of a novel eukaryotic ATPase family. , 1992, The Journal of biological chemistry.

[29]  K. Münger,et al.  Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein , 1992, Journal of virology.

[30]  R. Schiestl,et al.  Improved method for high efficiency transformation of intact yeast cells. , 1992, Nucleic acids research.

[31]  D. McCance,et al.  Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes , 1992, Journal of virology.

[32]  D. Lowy,et al.  The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture , 1991, Journal of virology.

[33]  A. Murray,et al.  Cyclin is degraded by the ubiquitin pathway , 1991, Nature.

[34]  G. Demers,et al.  The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells , 1991, Journal of virology.

[35]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[36]  H. Sato,et al.  Mutational analysis of human papillomavirus type 16 E7 functions , 1990, Journal of virology.

[37]  D. Lowy,et al.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. , 1989, The EMBO journal.

[38]  K. Münger,et al.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. , 1989, The EMBO journal.

[39]  R. Schlegel,et al.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes , 1989, Journal of virology.

[40]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[41]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[42]  H. Ruley,et al.  Two regions of the adenovirus early region 1A proteins are required for transformation , 1988, Journal of virology.

[43]  K. Randerath.  Chromatography of nucleotides on a new anion-exchange paper. , 1963, Journal of chromatography.